← Back
$LBRX All transactions

LB PHARMACEUTICALS INC

A

$ Value

Shares

175,706

Price

Filed

Sep 12

Insider

Name

Turner Heather D

Title

Chief Executive Officer

CIK

0001403571

Roles

Director Officer

Transaction Details

Transaction Date

2025-09-10

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

175,706

Footnotes

One fourth (1/4) of the shares subject to the option award shall vest on November 18, 2025 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date. | The transactions reported herein reflect a one-time stock option repricing, effective on September 10, 2025, which reduced the per share exercise price of each repriced option to $15, representing the initial public offering price of the Issuer's common stock (the "Option Repricing"). Except as modified by the Option Repricing, all other terms and conditions of the repriced options, including, without limitation, any provisions with respect to vesting, remain in full force and effect. | One fourth (1/4) of the shares subject to the option award shall vest on September 10, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Filing Info

Accession No.

0001415889-25-024442

Form Type

4

Issuer CIK

0001691082

Turner Heather D's History

Date Ticker Type Value
2026-02-01 TERN A $0
2025-09-10 LBRX D
2025-09-10 LBRX A
2025-09-10 LBRX D
2025-09-10 LBRX A
2025-09-10 LBRX A $0
2025-06-11 TERN A $0

Other Insiders at LBRX (90d)

Insider Bought Sold Last
Deep Track Biotechnology Master Fund, Ltd. $10.0M 2026-02-06
Lenz Robert A. 2026-03-06